JY
MRVI icon

Jeff Yass’s Maravai LifeSciences MRVI Stock Holding History

Jeff Yass’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
57,593
-129,046
-69% -$557K ﹤0.01% 10652
2026
Q1 		$528K Buy
+186,639
New +$633K ﹤0.01% 9527
2025
Q4 		– Sell
-67,538
Closed -$227K – 13137
2025
Q3 		$194K Sell
67,538
-169,552
-72% -$433K ﹤0.01% 11029
2025
Q2 		$571K Sell
237,090
-72,453
-23% -$152K ﹤0.01% 8864
2025
Q1 		$684K Buy
309,543
+181,225
+141% +$716K ﹤0.01% 8199
2024
Q4 		$699K Buy
128,318
+115,007
+864% +$740K ﹤0.01% 7827
2024
Q3 		$111K Sell
13,311
-96,368
-88% -$833K ﹤0.01% 10984
2024
Q2 		$785K Sell
109,679
-291,458
-73% -$2.52M ﹤0.01% 7159
2024
Q1 		$3.48M Sell
401,137
-187,005
-32% -$1.27M ﹤0.01% 4238
2023
Q4 		$3.85M Sell
588,142
-366,597
-38% -$2.37M ﹤0.01% 4160
2023
Q3 		$9.55M Sell
954,739
-1,484,339
-61% -$16.3M ﹤0.01% 2631
2023
Q2 		$30.3M Buy
2,439,078
+1,765,967
+262% +$23.8M 0.01% 1359
2023
Q1 		$9.43M Buy
673,111
+517,180
+332% +$7.43M ﹤0.01% 2541
2022
Q4 		$2.23M Buy
155,931
+32,915
+27% +$518K ﹤0.01% 4504
2022
Q3 		$3.14M Sell
123,016
-92,135
-43% -$2.31M ﹤0.01% 3990
2022
Q2 		$6.11M Buy
215,151
+171,398
+392% +$5.43M ﹤0.01% 2866
2022
Q1 		$1.54M Buy
43,753
+32,744
+297% +$1.1M ﹤0.01% 6071
2021
Q4 		$461K Buy
11,009
+4,200
+62% +$170K ﹤0.01% 9422
2021
Q3 		$334K Sell
6,809
-6,921
-50% -$338K ﹤0.01% 10342
2021
Q2 		$573K Sell
13,730
-29,769
-68% -$1.15M ﹤0.01% 9280
2021
Q1 		$1.55M Buy
+43,499
New +$1.44M ﹤0.01% 6553

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Jeff Yass's MRVI Position: Q2 2026 in Review

Jeff Yass reduced its Maravai LifeSciences (MRVI) stake by 69% in Q2 2026, selling an estimated $557K and leaving 57,593 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #10652.

Jeff Yass first reported a position in MRVI in Q1 2021 and has held it in 21 quarters since. The position peaked at $30.3M in Q2 2023. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Jeff Yass held 57,593 shares of Maravai LifeSciences worth $359K as of Q2 2026.
  • Jeff Yass sold 129,046 Maravai LifeSciences shares in Q2 2026, an estimated $557K.
  • Maravai LifeSciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10652 holding.
  • Jeff Yass first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 21 quarters since.
  • Jeff Yass's Maravai LifeSciences position peaked at $30.3M in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.